| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $501,911 ) |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F99AG079813 | Reversing age-related epigenetic changes and characterizing microglia heterogeneity in obesity and aging | 000 | 2 | NIH | 10/25/2023 | $36,513 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA225439 | Tribally Engaged Approaches to Lung Screening (TEALS) | 000 | 5 | NIH | 11/15/2023 | $385,352 |
| | 2024 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H7600185 | Ryan White Part C Outpatient EIS Program | 00 | 28 | HRSA | 11/16/2023 | $212,514 |
| | 2024 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01EY019494 | Role of Caveolin-1 in the Maintenance of Blood-retinal Barrier Integrity | 000 | 12 | NIH | 10/19/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA281098 | Development of contrast agents to facilitate image-guided surgery | 000 | 1 | NIH | 10/25/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AG071778 | The effects of a novel, non-ischemic and pain-free exercise intervention in peripheral artery disease | 000 | 1 | NIH | 11/8/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | NU58DP007727 | Building Capacity for and Promoting Awareness of Evidence-based Prevention and Management of Chronic Venous Thromboembolism | 01 | 1 | CDC | 11/30/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | U54HD113173 | Center for Indigenous Resilience, Culture, and Maternal Health Equity | 000 | 1 | NIH | 10/18/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | P30CA225520 | Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening among American Indians in Oklahoma | 000 | 6 | NIH | 11/20/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | P20GM134973 | Oklahoma Center for Microbial Pathogenesis and Immunity | 000 | 4 | NIH | 11/6/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R33CA253600 | Mobile Health Technology for Personalized Tobacco Cessation Support in Laos | 000 | 3 | NIH | 11/1/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | P20GM125528 | CELLULAR AND MOLECULAR GEROSCIENCE CoBRE | 000 | 5 | NIH | 10/19/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R33CA253600 | Mobile Health Technology for Personalized Tobacco Cessation Support in Laos | 000 | 3 | NIH | 11/1/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | UH735353 | Regional Genetics Networks | 02 | 4 | HRSA | 10/19/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | U1Q33082 | Geriatrics Workforce Enhancement Program | 03 | 5 | HRSA | 11/3/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | T9952111 | Value-Based Medical Student Education Training Program | 01 | 1 | HRSA | 11/15/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H4B15502 | Poison Control Stabilization and Enhancement Program | 02 | 15 | HRSA | 11/9/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H3306689 | EMSC Partnership Grants | 02 | 18 | HRSA | 11/28/2023 | $0 |
| | 2024 | 2022 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H3306689 | EMSC Partnership Grants | 02 | 18 | HRSA | 11/28/2023 | $12,093 |
| | 2024 | 2022 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H3306689 | EMSC Partnership Grants | 02 | 17 | HRSA | 11/9/2023 | -$12,094 |
| | 2024 | 2022 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R18HS027913 | Addressing Opioid Use Disorder in Older Adults through Primary Care Innovation (OUD-PCI) | 000 | 3 | AHRQ | 11/24/2023 | $0 |
| | 2024 | 2022 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01EY024951 | Immunobiology of EAU Recovery Through the Melanocortin-Adenosinergic Pathway | 000 | 7 | NIH | 10/24/2023 | -$19,697 |
| | 2024 | 2021 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21AG065720 | Novel mechanisms of aging-associated hyper-susceptibility to hepatotoxicity and liver injury | 000 | 2 | NIH | 11/29/2023 | $0 |
| | 2024 | 2021 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01HL135165 | Autoimmune Mechanisms in Human Myocarditis | 000 | 5 | NIH | 10/20/2023 | $0 |
| | 2024 | 2021 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | K23NS091430 | Radiographic markers of clinical function in Cervical Spondylotic Myelopathy | 001 | 5 | NIH | 11/2/2023 | -$2,815 |
| | 2024 | 2021 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | K23NS091430 | Radiographic markers of clinical function in Cervical Spondylotic Myelopathy | 000 | 5 | NIH | 11/2/2023 | -$2,830 |
| | 2024 | 2021 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | 90DDC50051 | Expanding Disabilities Network's (UCEDD's): Access to COVID 19 Vaccines | 03 | 1 | ACL | 10/27/2023 | -$68,846 |
| | 2024 | 2021 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21MD014658 | Improving the representativeness of American Indian Tribal Behavioral Risk Factor Surveillance System (TBRFSS) by machine learning and propensity score based data integration approach A1 | 000 | 2 | NIH | 10/10/2023 | -$1,738 |
| | 2024 | 2020 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R15DE028448 | Ecological shift of microbiome of oral microcosm biofilms due to resin biodegradation | 000 | 1 | NIH | 11/28/2023 | -$4,869 |
| | 2024 | 2020 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DA046359 | Measuring young adult appeal for menthol cigarettes using laboratory and intensivelongitudinal methods | 000 | 3 | NIH | 11/20/2023 | -$31,650 |
| | 2024 | 2020 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA203108 | Prognostic Biomarkers for ZIP4-mediated Cachexia in Pancreatic Cancer | 000 | 6 | NIH | 11/21/2023 | -$23 |
| | 2024 | 2019 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | 90FPSG0025 | Oklahoma Healthy Aging Initiative Falls Prevention Education Programs | 05 | 1 | ACL | 10/19/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $86,285,745 ) (Continued on the next page) |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H79SM085083 | Stronger Together: Attachment, Resilience, & Support (STARS): Helping Children and Youth Reach Their Full Potential | 001 | 1 | SAMHSA | 2/24/2023 | $0 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21AG072137 | A New Translational Rat Model for Evaluating Anti-Aging Interventions | 001 | 2 | NIH | 7/13/2023 | $229,626 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA260449 | Exploiting gold nanoparticle as a probe to identify therapeutic targets | 001 | 2 | NIH | 3/15/2023 | $31,019 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA251451 | Mobile Contingency Management for Smoking Cessation among Socioeconomically Disadvantaged Adults | 000 | 3 | NIH | 3/29/2023 | $596,014 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | E0133149 | Nurse Faculty Loan Program | 00 | 2 | HRSA | 6/29/2023 | $185,943 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA233613 | Role of the DNPH1 Enzyme in Breast Cancer | 000 | 5 | NIH | 2/2/2023 | $350,063 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | U1Q33082 | Geriatrics Workforce Enhancement Program | 02 | 5 | HRSA | 9/1/2023 | $5,678 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | U1Q33082 | Geriatrics Workforce Enhancement Program | 01 | 5 | HRSA | 7/10/2023 | $114,733 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | U1Q33082 | Geriatrics Workforce Enhancement Program | 01 | 5 | HRSA | 7/10/2023 | $1,600 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 Research Pkwy Ste 530 | Oklahoma City | OK | 73104-3609 | OKLAHOMA | USA | U1Q33082 | Geriatrics Workforce Enhancement Program | 00 | 5 | HRSA | 4/21/2023 | $749,541 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01EY035282 | Regulators of Photoreceptor Aerobic Glycolysis in Retinal Health and Disease | 000 | 1 | NIH | 8/29/2023 | $429,322 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | T9449364 | Advanced Nursing Education Workforce | 00 | 1 | HRSA | 6/23/2023 | $649,905 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | U19AI174994 | Advancing a second generation C. difficile vaccine | 000 | 1 | NIH | 7/24/2023 | $1,315,168 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 530 | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H79SM085083 | Stronger Together: Attachment, Resilience, & Support (STARS): Helping Children and Youth Reach Their Full Potential | 001 | 1 | SAMHSA | 2/24/2023 | $0 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK130174 | Developing proinsulin misfolding inhibitors for beta cell protection and diabetes treatment | 000 | 2 | NIH | 8/1/2023 | $384,202 |
| | 2023 | 2023 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01MH125998 | Regulation of Oxytocin Receptor Signaling in Neurons | 000 | 2 | NIH | 4/17/2023 | $42,500 |
|
